Important article by some highly experienced and thoughtful authors. These tips are easily applicable to other fields of medical devices but certainly crucial for neurotech startups. The question of developing an approach to intellectual property really resonates for me particularly when it comes to developing hardware for brain implants. Developing hardware in house gives you much more control of the product and IP but at a great expense and may make it more challenging to achieve market acceptance. I would certainly encourage all founding teams to make sure they have a discussion on each of these points and if they don't have an answer for them at least know who they are going to turn to for answers and at what stage in their roadmap.
In neurotech, bridging the gap between discovery and market launch— aka the ‘Valley of Death’—requires more than just great technology. We've seen this play out time and again: promising innovations fall short of their potential when critical elements like regulatory, IP, reimbursement, and clinical strategy are treated as downstream considerations rather than core building blocks. By addressing these challenges early on, founders can establish a viable path to market—or make necessary adjustments to avoid costly setbacks down the road. Our CEO, Liron Nunez Weissman and US Partnerships Lead, JoJo Platt map out the 7 components that help neurotech startups scale the ‘Mountain of Opportunity’—and why integrating them from day one is more crucial than most founders realize >> https://lnkd.in/dW_BXwpv #neuroscience #neurotech #startups #innovation